Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mendelics | RCV000989170 | SCV001139390 | pathogenic | Leber congenital amaurosis 1 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000995111 | SCV001149114 | likely pathogenic | not provided | 2017-09-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001228179 | SCV001400565 | pathogenic | Cone-rod dystrophy 13; Leber congenital amaurosis 6 | 2022-04-17 | criteria provided, single submitter | clinical testing | This sequence change affects a donor splice site in intron 5 of the RPGRIP1 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in RPGRIP1 are known to be pathogenic (PMID: 11528500, 23105016). This variant is present in population databases (rs376500610, gnomAD 0.003%). Disruption of this splice site has been observed in individuals with Leber congenital amaurosis (PMID: 30576320, 32865313). This variant is also known as IVS5+1G>A. ClinVar contains an entry for this variant (Variation ID: 803002). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. |
Genome- |
RCV001800907 | SCV002044725 | pathogenic | Leber congenital amaurosis 6 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001800908 | SCV002044736 | pathogenic | Cone-rod dystrophy 13 | 2021-11-07 | criteria provided, single submitter | clinical testing |